China Artificial Intelligence (AI) in Healthcare Market (2025-2030)
The China Artificial Intelligence (AI) in Healthcare Market was valued at $1644.9 Million in 2025 and projected to reach to $9049.8 Million by 2030, representing a compound annual growth rate of CAGR: 40.6%. China's AI in healthcare market is positioned for unprecedented growth, driven by government mandates for digital transformation, increasing healthcare expenditure, and the nation's technological prowess in artificial intelligence development.
China Artificial Intelligence (AI) in Healthcare Market Trends and Insights
- This exceptional growth trajectory reflects China's strategic investments in digital health infrastructure and government-backed AI initiatives across diagnostic imaging, drug discovery, and clinical decision support systems.
- China's healthcare sector is increasingly adopting AI-powered solutions to address physician shortages and improve patient outcomes in both urban and rural regions. The forecast period from 2025 to 2030 represents a critical phase for China's healthcare AI adoption, driven by regulatory support, rising healthcare expenditure, and integration of machine learning into hospital management systems.
- China's competitive advantage in AI talent and computational resources positions the nation as a regional leader in healthcare technology innovation.
- Major healthcare institutions and technology companies in China are collaborating to deploy AI solutions that enhance diagnostic accuracy and operational efficiency across the healthcare ecosystem..
Key Market Statistics
- CAGR (2025-2030) CAGR: 40.6%
- Market Size, 2025 ~USD 1644.9 Million
- Forecast, 2030 ~USD 9049.8 Million
- Country China
China Artificial Intelligence (AI) in Healthcare Market Overview
Explosive Growth Trajectory :
China's AI in healthcare market is projected to grow from USD 1,644.9 million in 2025 to USD 9,049.8 million by 2030, representing a remarkable 40.6% CAGR, outpacing the global average of 38.6%.
Government-Backed AI Initiatives :
China's strategic investments in digital health infrastructure and state-sponsored AI programs are driving adoption across diagnostic imaging, drug discovery, and clinical decision support systems nationwide.
Key Application Areas :
Primary focus areas include AI-powered diagnostic imaging for early disease detection, accelerated drug discovery pipelines, and intelligent clinical decision support systems enhancing physician capabilities across Chinese healthcare facilities.
Market Consolidation Opportunity :
The rapidly expanding market presents significant consolidation opportunities for healthcare providers, technology vendors, and pharmaceutical companies seeking to establish or expand their presence in China's digital health ecosystem.
China Artificial Intelligence (AI) in Healthcare Market Dynamics
- The market's 40.6% CAGR reflects strong demand from hospitals, diagnostic centers, and pharmaceutical companies seeking to modernize operations and improve patient outcomes through AI-enabled solutions. Looking ahead, China's aging population and rising chronic disease burden will further accelerate AI adoption in healthcare.
- Strategic partnerships between domestic tech giants and healthcare institutions, combined with regulatory frameworks supporting innovation, will create a competitive landscape favoring early movers and integrated solution providers capable of addressing China's unique healthcare challenges..
Related Ecosystem
Diagnostic Imaging
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- CT Scanners
- Nuclear Imaging
- Positron Emission Tomography
- Siemens healthineers
- PHILIPS HEALTHCARE
- CANON INC.
- FUJIFILM Holdings Corporation
- UNITED IMAGING HEALTHCARE CO., LTD.
Healthcare Analytics
- Machine Learning
- Natural Language Processing (NLP)
- Blood Pressure Monitors
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Oracle Corporation
- PHILIPS HEALTHCARE
- Siemens healthineers
- Zensar Technologies Limited
- EPIC SYSTEMS CORPORATION
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- China's AI in healthcare market is projected to grow from USD 21.63 million in 2025 to USD 110.61 million by 2030, representing a 38.6% CAGR.
- China's government support and digital health initiatives are accelerating AI adoption across diagnostic imaging, drug discovery, and clinical decision support.
- China's healthcare AI solutions are addressing critical gaps in physician availability and improving diagnostic accuracy in both urban and rural settings.
- China's technological infrastructure and AI talent pool position it as a leading regional hub for healthcare AI innovation and deployment.
Artificial Intelligence (AI) in Healthcare Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Forecast Period | 2025–2039 |
| Growth Rate | CAGR of 38.6% from 2025 to 2039 |
| Market Size Base Year (Billions) | ~USD 21.63 (2025) |
| Revenue Forecast (Billions) | ~USD 110.61 (2039) |
| Segments Covered | Offering, Function, Type, Technology, Application, Modality, Deployment Model, Tool, End User |
China Artificial Intelligence (AI) in Healthcare Market Report Segmentation
9 segment dimensions are covered across the global market.
By Offering
- AI Technologies
- Integrated Solutions
- Niche/Point Solutions
- Services
By Function
- Administrative
- Data Management & Analytics
- Diagnosis & Early Detection
- Patient Engagement & Remote Monitoring
- Pharmacy Management
- Post-Treatment Surveillance & Survivorship Care
- Treatment Planning & Personalization
By Type
- Ambulatory Care Centers
- Asset Management
- Auto Coding
- Behavioral Therapy & Psychotherapy
- Billing & Claims Management
- Classification & Categorization
- Compliance & Documentation
- Convolutional Neural Networks (Cnn)
- Customer Relationship Management
- Cybersecurity
- Deep Learning
- Device Context
- Diagnostic & Imaging Centers
- Diagnostic Imaging
- Diagnostics Imaging
- Dosing & Administration
- Drug Allergy Alerting
- Drug Response Prediction
- Eprescribing
- Follow-Up & Long-Term Support
- Fraud Detection & Risk Management
- Generative Adversarial Networks (Gan)
- Graph Neural Networks (Gnn)
- Healthcare Assistance Robots
- Healthcare Workflow Management
- Home Healthcare Agencies & Assisted Living Facilities
- Hospitals & Clinics
- Immunotherapy
- Intraoperative Guidance & Robotics
- Ivd
- Long-Term Outcome Prediction
- Medication Management
- Medication Reminders
- Mental Health & Support Systems
- Motion Synchronization & Auto Contouring
- Other Administrative Functions
- Other Deep Learning Tools
- Other Diagnosis & Early Detection Functions
- Other Healthcare Providers
- Other Machine Learning Tools
- Other ML Tools
- Other Patient Engagement & Remote Monitoring Functions
- Other Pharmacological Therapy Functions
- Other Pharmacy Management Functions
- Other Radiation Therapy Functions
- Other Treatment Planning & Personalization Functions
- Patient Education & Empowerment
- Patient Eligibility & Authorization
- Patient Registration & Scheduling
- Pattern & Image Recognition
- Personalized Treatment Planning
- Pharmacies
- Pharmacological Therapy
- Pharmacy Audit & Analysis
- Physical Context
- Postoperative Analysis & Recovery
- Pre-Screening
- Precision Medicine & Genomic Analysis
- Predictive Models For Treatment Response
- Preoperative Imaging & 3D Modeling
- Private Payers
- Progress Monitoring & Feedback
- Public Payers
- Radiation Therapy
- Real-Time Adaptive Treatment Delivery
- Real-Time Patient Data Monitoring
- Recurrence Monitoring
- Recurrent Neural Networks (Rnn)
- Reinforcement Learning
- Relapse Prediction & Long-Term Management
- Response & Side-Effect Prediction
- Response Assessment & Quality Assurance
- Risk Assessment & Patient Stratification
- Sentiment Analysis
- Speech Recognition
- Supervised Learning
- Supply Chain & Inventory Management
- Surgical Therapy
- Symptom Management & Virtual Assistance
- Telehealth & Remote Patient Monitoring
- Text Analytics
- Treatment Recommendation Systems
- Unsupervised Learning
- User Context
- Virtual Counseling & Chatbots
- Workforce Management
By Technology
- Clinical Chemistry
- Immunoassays
- Molecular Diagnostics
By Application
- Biomarker Discovery & Analysis
- Clinical Applications
- Disease Interpretation & Report Analysis
- Image Analysis & Interpretation
- Image Captioning & Annotation
- Image Reconstruction
- Non-Clinical Applications
- Other Diagnostic Imaging Applications
- Other Ivd Applications
By Modality
- Computed Tomography (Ct)
- Magnetic Resonance Imaging (Mri)
- Nuclear Imaging (Pet & Spect)
- Other Diagnostic Imaging Modalities
- Ultrasound
- X-Ray Imaging
By Deployment Model
- Cloud-Based Models
- Hybrid Models
- On-Premise Models
By Tool
- Computer Vision
- Context-Aware Computing
- Generative AI
- Image Analysis
- Machine Learning (ML)
- Natural Language Processing (Nlp)
By End User
- Healthcare Payers
- Healthcare Providers
- Other End Users
- Patients
Target Audience
- Healthcare Technology Vendors : AI software and platform providers need China-specific market data to assess market opportunity size, identify customer segments, and develop localized go-to-market strategies for diagnostic and clinical decision support solutions.
- Pharmaceutical & Biotech Companies : Drug discovery and development firms require insights into China's AI-enabled drug discovery market growth to evaluate partnership opportunities, licensing potential, and investment in AI-powered R&D capabilities.
- Healthcare Providers & Hospital Networks : Chinese hospitals and healthcare systems need market intelligence to benchmark AI adoption rates, identify best-in-class solutions, and justify capital investments in diagnostic imaging and clinical decision support technologies.
- Private Equity & Investment Firms : Investors and PE funds targeting China's healthcare sector require detailed market sizing and growth projections to identify acquisition targets, evaluate portfolio company performance, and structure healthcare AI investment strategies.
- Government & Policy Makers : Chinese health authorities and policy officials need market analysis to assess digital health infrastructure development, evaluate AI initiative effectiveness, and inform healthcare technology adoption and funding priorities.
Key Companies in the China Artificial Intelligence (AI) in Healthcare Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| EPAM SYSTEMS, INC. | United States | ||
| SIEMENS AG | Germany | ||
| WNS GLOBAL SERVICES | India | ||
| L&T TECHNOLOGY SERVICES LIMITED | India | ||
| LARSEN & TOUBRO INFOTECH LIMITED | India | ||
| SOPRA STERIA | United States | ||
| CYIENT | India |
EPAM SYSTEMS, INC.
EPAM Systems, Inc. is a leading digital transformation and software engineering services company headquartered in the United States. The company provides consulting, software development, and IT services to clients across various industries globally.
SIEMENS AG
Siemens AG is a German multinational conglomerate providing automation, digitalization, and electrification solutions across industrial, infrastructure, and mobility sectors worldwide.
WNS GLOBAL SERVICES
WNS Global Services is an India-based business process management and IT services company offering customer engagement, finance and accounting, and technology solutions to global enterprises.
L&T TECHNOLOGY SERVICES LIMITED
L&T Technology Services Limited is an India-based engineering and technology services company providing design, engineering, and digital transformation solutions across multiple industries.
LARSEN & TOUBRO INFOTECH LIMITED
Larsen & Toubro Infotech Limited is an India-based IT services and consulting company offering digital transformation, cloud, and enterprise solutions to global clients.
SOPRA STERIA
Sopra Steria is a digital services and software company providing consulting, systems integration, and software development services, with operations in the United States and globally.
CYIENT
Cyient is an India-based engineering and technology services company specializing in digital, engineering, and cloud solutions for aerospace, defense, and industrial sectors.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation data for China's AI healthcare sector with detailed CAGR projections through 2030, enabling accurate financial forecasting and investment decision-making for market entry or expansion strategies.
- Competitive Intelligence : Understand China-specific market dynamics, key application areas, and government initiatives to identify competitive advantages, partnership opportunities, and differentiation strategies within the rapidly evolving digital health landscape.
- Regulatory & Policy Insights : Access analysis of China's government-backed AI initiatives and digital health infrastructure policies that shape market opportunities, compliance requirements, and strategic priorities for healthcare technology vendors.
- Segment-Specific Opportunities : Identify high-growth segments including diagnostic imaging AI, drug discovery platforms, and clinical decision support systems with tailored market data to prioritize resource allocation and product development efforts.
- Risk Mitigation & Strategic Planning : Leverage comprehensive China market analysis to assess market saturation, competitive intensity, and growth sustainability, reducing investment risk and enabling data-driven strategic planning for healthcare AI ventures.
Frequently asked questions
What is the current market size of AI in healthcare in China?
China's AI in healthcare market was valued at USD 21.63 million in 2025 and is expected to grow significantly through 2030.
What is the projected growth rate for China's healthcare AI market?
China's AI in healthcare market is expected to grow at a compound annual growth rate (CAGR) of 38.6% from 2025 to 2030.
What will be the market size of AI in healthcare in China by 2030?
China's AI in healthcare market is projected to reach USD 110.61 million by 2030, reflecting substantial expansion over the forecast period.
What are the primary drivers of AI adoption in China's healthcare sector?
China's healthcare AI growth is driven by government support, rising healthcare expenditure, physician shortages, and integration of machine learning into hospital systems.
How does China's AI healthcare market compare to other Asia Pacific nations?
China's technological infrastructure, AI talent pool, and government backing position it as a leading regional player in healthcare AI innovation within Asia Pacific.
RESEARCH METHODOLOGY
The study involved significant efforts to estimate the current size of the artificial intelligence (AI) in healthcare market. Exhaustive secondary research was conducted to collect information on the artificial intelligence (AI) in healthcare market. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the artificial intelligence (AI) in healthcare market.
Secondary Research
This research study involved the extensive use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and Companies House documents; investor presentations; and companies' SEC filings. The market for companies offering artificial intelligence (AI) in healthcare solutions is derived from secondary data available through paid and unpaid sources, analysis of the product portfolios of major companies in the ecosystem, and ratings of companies based on performance and quality. Various sources were consulted during the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, company investor presentations, white papers, journals, certified publications, articles by recognized authors, directories, and databases.
Various secondary sources were consulted during the secondary research process to identify and collect information relevant to the study. These sources included annual reports, press releases, investor presentations of artificial intelligence (AI) in healthcare vendors, forums, certified publications, and whitepapers. Secondary research was used to obtain critical information on the industry’s value chain, the pool of key players, market classification, and segmentation from market- and technology-oriented perspectives.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess prospects.
Primary research was conducted to identify segmentation types, key players, and key market dynamics, including drivers, restraints, opportunities, challenges, and strategies adopted by key players.
After the complete market engineering (calculations for market statistics, market breakdown, market size estimates, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers derived.
In the complete market engineering process, top-down and bottom-up approaches, along with several data triangulation methods, were extensively used to perform market estimation and forecasting across the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analyses were conducted on the complete market engineering process to identify key information/insights throughout the report.
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by offering, function, application, deployment, tool, end user, and region).
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and obtain the exact statistics for each market segment and subsegment, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the artificial intelligence (AI) in healthcare market.
Market Definition
The artificial intelligence (AI) in healthcare market encompasses the application of AI technologies, such as machine learning, natural language processing, computer vision, and robotics, to improve healthcare delivery, enhance operational efficiency, and provide personalized care. These solutions address a wide range of use cases, including diagnostic imaging, predictive analytics, drug discovery, patient engagement, remote monitoring, and administrative workflows, enabling healthcare providers, payers, and pharmaceutical companies to drive innovation and improve outcomes.
Key Stakeholders
- Artificial intelligence (AI) in healthcare software vendors
- Artificial intelligence (AI) in healthcare service providers
- Independent software vendors (ISVs)
- Platform providers
- Technology providers
- System integrators
- Cloud service providers
- Healthcare IT service providers
- Hospitals and surgical centers
- Diagnostic imaging centers
- Academic institutes and research laboratories
- Forums, alliances, and associations
- Government organizations
- Institutional investors and investment banks
- Investors/Shareholders
- Venture capitalists
- Research and consulting firms
Report Objectives
- To define, describe, and forecast the global artificial intelligence (AI) in healthcare market based on offering, function, application, deployment, tool, end user, and region
- To provide detailed information regarding the factors influencing the growth of the market (such as the drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall artificial intelligence (AI) in healthcare market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the artificial intelligence (AI) in healthcare market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies in the market
- To track and analyze competitive developments such as product & service launches; expansions; partnerships, agreements, and collaborations; and acquisitions in the artificial intelligence (AI) in healthcare market
- To benchmark players within the artificial intelligence (AI) in healthcare market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Europe artificial intelligence (AI) in healthcare market into Denmark, Norway, and others
- Further breakdown of the Rest of Asia Pacific artificial intelligence (AI) in healthcare market into Vietnam, New Zealand, Australia, South Korea, and others
Get the Full Artificial Intelligence (AI) in Healthcare Market Report
Full forecast, segment splits, and company analysis for all Artificial Intelligence (AI) in Healthcare Market.
- US Artificial Intelligence (AI) in Healthcare Market
- Canada Artificial Intelligence (AI) in Healthcare Market
- Germany Artificial Intelligence (AI) in Healthcare Market
- UK Artificial Intelligence (AI) in Healthcare Market
- France Artificial Intelligence (AI) in Healthcare Market
- Italy Artificial Intelligence (AI) in Healthcare Market
- Spain Artificial Intelligence (AI) in Healthcare Market
- Japan Artificial Intelligence (AI) in Healthcare Market
- India Artificial Intelligence (AI) in Healthcare Market
- Brazil Artificial Intelligence (AI) in Healthcare Market
- Mexico Artificial Intelligence (AI) in Healthcare Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report